SYNDROX

Welcome to the Brand page for “SYNDROX”, which is offered here for Sympathomimetic preparation indicated in the treatment of mild depression or asthenic states, obesity, narcolepsy, as an adjunct in the treatment of acute and chronic alcoholism, postencephalitic parkinson's syndrome, cerebral arteriosclerosis, and migraine;.

Its status is currently believed to be active. Its class is unavailable. “SYNDROX” is believed to be currently owned by “MCNEIL LABORATORIES, INCORPORATED”.


Owner:
MCNEIL LABORATORIES, INCORPORATED
Owner Details
Description:
SYMPATHOMIMETIC PREPARATION INDICATED IN THE TREATMENT OF MILD DEPRESSION OR ASTHENIC STATES, OBESITY, NARCOLEPSY, AS AN ADJUNCT IN THE TREATMENT OF ACUTE AND CHRONIC ALCOHOLISM, POSTENCEPHALITIC PARKINSON'S SYNDROME, CEREBRAL ARTERIOSCLEROSIS, AND MIGRAINE;
Categories: SYMPATHOMIMETIC PREPARATION INDICATED IN